Health TrialsbyHealthPanel

Tamponade vs Partial Myometrial Resection of Lower Uterine Segment in Management of Placenta Accreta Spectrum Cases

ConditionPlacenta Accreta
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorAssiut University

About this trial

To compare the efficacy of lower uterine tamponade and partial lower myometrial resection in the management of intraoperative bleeding in cases with placenta accreta spectrum .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1-Pregnant women with placenta previa /PAS diagnosed before delivery (by ultrasound and Doppler examination) .

Disqualifiers

A pre-existing decision of performing intrapartum hysterectomy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Tamponade of lower uterine segment in management of placenta accreta spectrum cases

    Procedure/Surgery

    To compare the efficacy of lower uterine tamponade and partial lower myometrial resection in the management of intraoperative bleeding in cases with placenta accreta spectrum

  • partial myometrial resection of lower uterine segment in management of placenta accreta spectrum cases

    Procedure/Surgery

    tamponade vs partial myomertial resection of lower uterine segment in managment of placenta accreta spectrum cases

Treatment groups

222 Participants
are divided into 2 treatment groups
Group A: tamponade of lower uterine segmentin managment of placenta accreta spectrum casesActive comparator 1 intervention
Group B: partial myometrial resection of lower uterine segment in management of placenta accreta spectrumActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

amount of intraopertive blood loss.

compare of amount of blood loss between two methods by adding collected blood in suction apparatus in milliliters to amount of biood in the soaked towels

Time frame
2 years

Secondary outcomes

1

ICU admission

yes or no admission number of days if there is ICU admission cause of admission

Time frame
2 years
2

Re exploration

if there is exploration or no cause of re-exploration outcome of re-exploration

Time frame
2 years
3

drop of HB level postoperative

result of substitution of HB level postoperative from preoperative in gmldl

Time frame
2 years
4

blood transfusion

amount of transfused blood units

Time frame
2 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: